title: Protection of dopamine neurons by vibration training and up-regulation of brain-derived neurotrophic factor in a MPTP mouse model of Parkinson's disease.
abstract: It is unknown whether the longer duration of vibration training (VT) has a beneficial effect on Parkinson's disease (PD). And also, the mechanisms underlying the reported sensorimotor-improvement in PD induced by short-duration of VT has not been determined. Here, we investigated the effects of longer duration (4 weeks) of low amplitude vibration (LAV) training on the numbers of dopaminergic neurons in the substantia nigra by immunostaining and the levels of dopamine (DA) and brain-derived neurotrophic factor (BDNF) in the striatum by HPLC and ELISA in the chronic MPTP lesion mouse. We demonstrated for the first time that the longer duration of VT could significantly increase the numbers of nigrostriatal DA neurons and the contents of striatal DA and BDNF in the MPTP mice. Our findings implied that longer duration of VT could protect dopaminergic neurons from the MPTP-induced damage probably by upregulating BDNF and also provided evidence for the beneficial effect of longer duration of VT on PD at the cellular and molecular level.
authors.affiliation: Laboratory of Neuropharmacology and Department of Neurosurgery, South-west Hospital, The Third Military Medical University, Chongqing , China. zmqian1993@gmail.com and Department of Sports Physiology, Beijing Sport University, Beijing, China. zhaolispring@126.com.
authors.forename: L
authors.initials: L
authors.lastname: Zhao
authors.forename: L X
authors.initials: LX
authors.lastname: He
authors.forename: S N
authors.initials: SN
authors.lastname: Huang
authors.forename: L J
authors.initials: LJ
authors.lastname: Gong
authors.forename: L
authors.initials: L
authors.lastname: Li
authors.forename: Y Y
authors.initials: YY
authors.lastname: Lv
authors.forename: Z M
authors.initials: ZM
authors.lastname: Qian
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D059290:Dopaminergic Neurons / Q000378:metabolism*; D008297:Male; D008810:Mice, Inbred C57BL; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D013378:Substantia Nigra / Q000378:metabolism* / Q000503:physiopathology; D013997:Time Factors; D015854:Up-Regulation; D014732:Vibration
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine